October 10, 2006

AEI's Jack Calfee gives Richard Epstein's new book Overdose a sterling review in the New York Post.

Epstein hits just about every issue in today's intense debate over the pharmaceutical industry: patent rights, prices and price controls, drug importation at bargain-level foreign prices, R&D incentives and the role of government, FDA regulation (including drug-safety oversight), drug marketing and its many critics and tort liability.